Steminent Biotherapeutics Stock Forecast - Naive Prediction
| 7729 Stock | 83.80 0.90 1.09% |
Momentum 0
Sell Peaked
Oversold | Overbought |
Using Steminent Biotherapeutics hype-based prediction, you can estimate the value of Steminent Biotherapeutics from the perspective of Steminent Biotherapeutics response to recently generated media hype and the effects of current headlines on its competitors.
The Naive Prediction forecasted value of Steminent Biotherapeutics on the next trading day is expected to be 82.90 with a mean absolute deviation of 3.45 and the sum of the absolute errors of 141.51. Steminent Biotherapeutics after-hype prediction price | TWD 83.8 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Steminent |
Steminent Biotherapeutics Additional Predictive Modules
Most predictive techniques to examine Steminent price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Steminent using various technical indicators. When you analyze Steminent charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Steminent Biotherapeutics Naive Prediction Price Forecast For the 29th of January
Given 90 days horizon, the Naive Prediction forecasted value of Steminent Biotherapeutics on the next trading day is expected to be 82.90 with a mean absolute deviation of 3.45, mean absolute percentage error of 22.68, and the sum of the absolute errors of 141.51.Please note that although there have been many attempts to predict Steminent Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Steminent Biotherapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Steminent Biotherapeutics Stock Forecast Pattern
Steminent Biotherapeutics Forecasted Value
In the context of forecasting Steminent Biotherapeutics' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Steminent Biotherapeutics' downside and upside margins for the forecasting period are 77.39 and 88.41, respectively. We have considered Steminent Biotherapeutics' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Steminent Biotherapeutics stock data series using in forecasting. Note that when a statistical model is used to represent Steminent Biotherapeutics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 84.4744 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 3.4516 |
| MAPE | Mean absolute percentage error | 0.0576 |
| SAE | Sum of the absolute errors | 141.5136 |
Predictive Modules for Steminent Biotherapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Steminent Biotherapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Steminent Biotherapeutics Estimiated After-Hype Price Volatility
As far as predicting the price of Steminent Biotherapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Steminent Biotherapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Steminent Biotherapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Steminent Biotherapeutics Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Steminent Biotherapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Steminent Biotherapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Steminent Biotherapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
1.75 | 5.51 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | In 5 to 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
83.80 | 83.80 | 0.00 |
|
Steminent Biotherapeutics Hype Timeline
Steminent Biotherapeutics is presently traded for 83.80on Taiwan OTC Exchange of Taiwan. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Steminent is anticipated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is anticipated to be very small, whereas the daily expected return is presently at 1.75%. %. The volatility of related hype on Steminent Biotherapeutics is about 0.0%, with the expected price after the next announcement by competition of 83.80. Assuming the 90 days trading horizon the next anticipated press release will be in 5 to 10 days. Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.Steminent Biotherapeutics Related Hype Analysis
Having access to credible news sources related to Steminent Biotherapeutics' direct competition is more important than ever and may enhance your ability to predict Steminent Biotherapeutics' future price movements. Getting to know how Steminent Biotherapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Steminent Biotherapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| 6895 | Wave Power Technology | 0.00 | 0 per month | 0.00 | (0.14) | 4.29 | (6.39) | 16.72 | |
| 6788 | Brillian Network Automation | 0.00 | 0 per month | 2.75 | 0.15 | 4.62 | (4.24) | 17.07 | |
| 4931 | STL Technology Co | 0.00 | 0 per month | 3.50 | 0.05 | 6.45 | (5.78) | 17.89 | |
| 1537 | Kung Long Batteries | 0.00 | 0 per month | 0.00 | (0.11) | 1.22 | (1.20) | 4.02 | |
| 1615 | Dah San Electric | 0.00 | 0 per month | 0.55 | 0.07 | 1.98 | (1.21) | 5.15 | |
| 6115 | I Sheng Electric Wire | 0.00 | 0 per month | 0.29 | (0.16) | 0.74 | (0.63) | 1.91 | |
| 3015 | FSP Technology | 0.00 | 0 per month | 0.00 | (0.05) | 3.91 | (3.42) | 10.63 | |
| 2489 | Amtran Technology Co | 0.00 | 0 per month | 1.60 | 0.19 | 9.84 | (2.96) | 15.51 | |
| 8109 | P Duke Technology Co | 0.00 | 0 per month | 1.08 | 0.06 | 2.82 | (2.18) | 7.13 |
Other Forecasting Options for Steminent Biotherapeutics
For every potential investor in Steminent, whether a beginner or expert, Steminent Biotherapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Steminent Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Steminent. Basic forecasting techniques help filter out the noise by identifying Steminent Biotherapeutics' price trends.Steminent Biotherapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Steminent Biotherapeutics stock to make a market-neutral strategy. Peer analysis of Steminent Biotherapeutics could also be used in its relative valuation, which is a method of valuing Steminent Biotherapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Steminent Biotherapeutics Market Strength Events
Market strength indicators help investors to evaluate how Steminent Biotherapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Steminent Biotherapeutics shares will generate the highest return on investment. By undertsting and applying Steminent Biotherapeutics stock market strength indicators, traders can identify Steminent Biotherapeutics entry and exit signals to maximize returns.
| Accumulation Distribution | 27861.32 | |||
| Daily Balance Of Power | 0.2308 | |||
| Rate Of Daily Change | 1.01 | |||
| Day Median Price | 83.85 | |||
| Day Typical Price | 83.83 | |||
| Price Action Indicator | 0.4 | |||
| Period Momentum Indicator | 0.9 |
Steminent Biotherapeutics Risk Indicators
The analysis of Steminent Biotherapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Steminent Biotherapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting steminent stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 4.06 | |||
| Semi Deviation | 2.17 | |||
| Standard Deviation | 5.51 | |||
| Variance | 30.39 | |||
| Downside Variance | 9.95 | |||
| Semi Variance | 4.7 | |||
| Expected Short fall | (5.76) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Steminent Biotherapeutics
The number of cover stories for Steminent Biotherapeutics depends on current market conditions and Steminent Biotherapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Steminent Biotherapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Steminent Biotherapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Additional Tools for Steminent Stock Analysis
When running Steminent Biotherapeutics' price analysis, check to measure Steminent Biotherapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Steminent Biotherapeutics is operating at the current time. Most of Steminent Biotherapeutics' value examination focuses on studying past and present price action to predict the probability of Steminent Biotherapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Steminent Biotherapeutics' price. Additionally, you may evaluate how the addition of Steminent Biotherapeutics to your portfolios can decrease your overall portfolio volatility.